Article info

Download PDFPDF
Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary
  1. Correspondence to Tomokazu Umezu, Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan; t-ume{at}med.nagoya-u.ac.jp
View Full Text

Citation

Umezu T, Shibata K, Kajiyama H, et al
Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary

Publication history

  • Accepted July 14, 2010
  • First published October 23, 2010.
Online issue publication 
October 23, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.